medscape.com
Study Reveals Racial Disparities in IBD Healthcare
The study highlights racial and ethnic disparities in access to IBD care — including specialist visits, use of advanced therapies, and emergency services — which can affect disease management and outcomes. Recognizing these gaps can inform efforts to improve equity in IBD care delivery.
Adult patients with IBD (especially Asian, Hispanic, and Black American patients), caregivers, gastroenterologists, health services researchers, and policymakers focused on health equity.
What To Know
Study summary: A retrospective cohort study of insurance claims (Optum CDM and Medicare) examined racial and ethnic differences in healthcare use among people with IBD.
Key findings reported lower outpatient and advanced-therapy use among Asian and Hispanic adults and greater emergency-department use among older Black adults; some disparities in working-age Black adults were attenuated after adjusting for socioeconomic factors.
The article reports differences in how often people from different racial and ethnic groups accessed IBD care — including visits to gastroenterologists, use of advanced therapies, steroid prescribing, emergency visits, hospitalizations, and diagnostic procedures.
The authors highlight access and equity concerns and call for further research and policy work to address disparities.
How this might affect patients: If you belong to a historically marginalized group or care for someone who does, this study raises concerns that access to specialists, advanced treatments, and outpatient care may be lower and emergency care use higher for some groups. It does not provide individual treatment recommendations or change clinical guidance.
Source note: The underlying research was published in The American Journal of Gastroenterology and analyzed large claims datasets; the Medscape article summarizes those results for a clinical audience.
This was an observational claims-based study with limitations including race/ethnicity classification methods, exclusion of some insured groups (Medicaid under‑65), and analyses limited to a single year for utilization measures. The article is a news summary of the peer-reviewed study and does not change clinical recommendations.
